Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.291ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.291ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.291EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.291EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.291ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.291ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-19663.3China
B.1.258EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
B.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.349EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.349ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.349ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.349EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.349EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.349ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.349ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.314EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.314EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.314ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.314ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.314EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.314EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.314ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.314ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.132EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.132EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.132ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.132ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.132EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.132EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.132ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.132ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.16.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.16.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.16.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.16.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.16.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.9.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used